Dudediligence.

Plus Therapeutics, Inc

PSTVNASDAQ · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.5MSep ’24$1.4MDec ’24$1.1MMar ’25$1.4MJun ’25$1.4MSep ’25$1.4MDec ’25$1.0MMar ’26$411,000Jun ’26
Net income, by quarter
−$2.9MSep ’24−$3.9MDec ’24−$17.4MMar ’25$5.2MJun ’25−$4.4MSep ’25−$5.7MDec ’25−$6.9MMar ’26−$9.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on file$4.9M$5.8M$5.2M
Operating income−$12.5M−$19.7M−$13.3M−$14.7M−$15.3M
Net income−$13.4M−$20.3M−$13.3M−$13.0M−$22.4M
Operating cash flow−$10.3M−$13.0M−$12.9M−$10.6M−$20.8M
Free cash flownone on filenone on file−$13.0M−$10.7M−$20.8M
Cash$18.4M$18.1M$8.6M$76,000$4.3M
Debt$6.6M$5.4M$4.0Mnone on filenone on file
Shares outstanding15.5M2.2M4.4M5.9M138.7M